A proteomic analysis of the urine revealed APPs (FGA, FGG, HP, ITI4, SERPINA1) [20] as biomarkers for prostate cancer, but the paper lacks the analysis of their pathophysiological role. The gene discussed is FGG; the disease is Familial prostate cancer.